Ontology highlight
ABSTRACT: Objective
Minimal residual disease assessment of BCR-ABL messenger ribonucleic acid levels is crucial in Philadelphia chromosome-positive acute lymphoblastic leukemia for prognosis and treatment planning. However, accurately quantifying minor BCR-ABL transcripts, which comprise 70% of Philadelphia chromosome-positive acute lymphoblastic leukemia cases, lacks a national-approved method.Methods
We developed the "Otsuka" minor BCR-ABLmessenger ribonucleic acid assay kit with exceptional precision (0.00151%). Minor BCR-ABL messenger ribonucleic acid levels were analyzed in 175 adults, 36 children with acute lymphoblastic leukemia and 25 healthy individuals to evaluate the kit's performance.Results
The "Otsuka" kit showed high concordance with a commonly used chimeric ge
SUBMITTER: Hidaka M
PROVIDER: S-EPMC10849185 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature